Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy-Reference-Cited by-同舟云学术

Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy

Published:2017-06 Issue:22 Volume:96 Page:e6874
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Mitani Seiichiro,Kadowaki Shigenori,Komori Azusa,Sugiyama Keiji,Narita Yukiya,Taniguchi Hiroya,Ura Takashi,Ando Masashi,Sato Yozo,Yamaura Hidekazu,Inaba Yoshitaka,Ishihara Makoto,Tanaka Tsutomu,Tajika Masahiro,Muro Kei

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference25 articles.

1. Capecitabine: effective oral fluoropyrimidine chemotherapy;McKendrick;Expert Opin Pharmacother,2005

2. 5-fluorouracil: mechanisms of action and clinical strategies;Longley;Nat Rev Cancer,2003

3. S-1: a promising new oral fluoropyrimidine derivative;Saif;Expert Opin Investig Drugs,2009

4. High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy;Yeh;Br J Cancer,1997

5. Weekly high-dose 5-fluorouracil (5-FU), leucovorin (LV) and bimonthly cisplatin in patients with advanced gastric cancer;Lin;Jpn J Clin Oncol,2001

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperammonaemia: review of the pathophysiology, aetiology and investigation;Pathology;2024-10

2. Adverse drug events associated with fluorouracil use in patients with metastatic colorectal cancer: a real-world pharmacovigilance study based on the FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-07-23

3. Chemotherapy-Induced Changes in Plasma Amino Acids and Lipid Oxidation of Resected Patients with Colorectal Cancer: A Background for Future Studies;International Journal of Molecular Sciences;2024-05-13

4. Mitochondrial targets in hyperammonemia: Addressing urea cycle function to improve drug therapies;Biochemical Pharmacology;2024-04

5. Impaired Consciousness Due to Hyperammonemia During S-1 Administration for Unresectable Pancreatic Cancer;Internal Medicine;2024